Advertisement

CURE TV®

With CURE TV®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

SABCS: Debu Tripathy Discusses Immunotherapy in Breast Cancer

December 12th 2014

Debu Tripathy, editor-in-chief of CURE magazine, recaps the first day of the San Antonio Breast Cancer Symposium - namely the advances in treating breast cancer with immunotherapy.

Greenberger Explains Why Immunotherapy Will Be an Important Class of Therapies for Blood Cancers

December 10th 2014

Lee Greenberger, of the Leukemia & Lymphoma Society, explains how immunotherapy research has progressed in hematological cancers and the potential for these burgeoning therapies.

MMRF's CoMMpass Study Highlights and Moves Research of Myeloma Forward

December 10th 2014

Anne Young Quinn, of the MMRF, explains the catalyst behind the CoMMpass study and how it may be changing the future of myeloma treatment.

Oncologist Richard T. Silver on Receiving the MPN Hero Award

December 6th 2014

Richard Silver, an oncologist focused on rare blood diseases called myeloproliferative neoplasms was named an MPN Hero for Commitment to the Broader MPN Community for 2014.

David Alexander on the MPN Heroes Program

December 6th 2014

David Alexander was selected as an MPN Hero at this year's MPN Heroes event. The MPN Heroes event honors clinicians, caregivers, and advocates who have made significant contributions in the field of myeloproliferative neoplasms (MPNs).

Antje Hjerpe Discusses Her Passion for the MPN Community

December 6th 2014

Antje Hjerpe was nominated as an MPN Hero for her long-term dedication, stewardship and volunteer service to the organization.

Artist's Balancing Act Inspires New York's Hope Murals Project

November 13th 2014

New York artist and GIST survivor, Ellen Mayer, painted "Balancing Act" to describe how she felt about her cancer experience. The artwork was later selected as one of 10 pieces to be publicly painted for The Hope Murals Project.

Oncology on Canvas Winner's Cancer Experience Shapes Her Artwork

October 31st 2014

Susan Hope Schaffer, the 2014 Oncology on Canvas overall winner, shares how her experience with breast cancer helped her evolve as an artist.

Oncology on Canvas and The Hope Murals Project Reaches New York City

October 31st 2014

For the 10th anniversary of the Oncology on Canvas art competition, Lilly Oncology and the National Coalition for Cancer Survivorship created The Hope Murals Project, a traveling exhibit throughout the U.S.

How Will Breast Cancer Surgery and Treatment Improve Over the Next Five Years?

October 16th 2014

Patrick Borgen, MD, talks about advances in breast cancer surgery, faster clinical trials, and better genomic profiling.

Patrick Borgen, MD, on the Future of Personalized Medicine in Breast Cancer Care

October 16th 2014

Breast cancer is a complicated family of diseases – the goal is personalized medicine, and a team-based approach should be the standard of care.

Latest Updates in Cancer Research Announced at European Oncology Congress

October 9th 2014

Several studies announcing the latest research in different cancers, including prostate, breast and lung cancers, were presented at the 2014 European Society of Medical Oncology's annual meeting in Madrid, Spain.

The Ongoing Mammography Debate: Does Routine Screening Matter?

October 2nd 2014

Patrick Borgen, MD, discusses the benefits of early detection versus overtreatment of breast cancer associated with routine breast cancer screening.

Does Prophylactic Double Mastectomy Make a Difference?

October 2nd 2014

Patrick Borgen, MD, shares his thoughts on the ethics and the efficacy of undergoing pre-emptive double mastectomy in women who have a BRCA mutation, which can greatly increase their risk for breast and ovarian cancers.

Dana-Farber Leads Kadcyla ATEMPT Study in HER2-Positive Breast Cancer

October 1st 2014

Experts review an innovative study, called the ATEMPT study, which looks at adjuvant T-DM1 in women with HER2-positive breast cancer.

ASCO: Early Studies Show Promise in Treating Metastatic Breast Cancer

June 5th 2014

Debu Tripathy, MD, editor-in-chief of CURE magazine, shares the latest research in metastatic breast cancer, including targeted drugs being tested in early-phase studies that appear promising, including the PARP inhibitor veliparib, the CDK4/6 inhibitor palbociclib and the anti-angiogenesis drug trametinib.

PREVIOUS PAGE
Advertisement
Advertisement